The nomination of Oz has spurred questions about the incoming administration's approach to public health, access to care and reforming insurance policy.
Jack O'Brien is a journalist who specializes in healthcare and pharmaceutical industry news. He writes for publications such as MM+M and The Clinical Advisor, and his work has also been featured in PRWeek. Jack covers topics ranging from FDA approvals and industry trends to healthcare crises and advancements in medical treatments.